Historical overview of chemical carcinogenesis

Current Cancer Research

Volumn 6, Issue , 2011, Pages 1-26

  Harvey, Ronald G ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AFLATOXIN; AMIDE; AROMATIC AMINE; AROMATIC NITRO COMPOUND; CARCINOGEN; CATION; ESTRAGOLE; HETEROCYCLIC AMINE; NITROSO DERIVATIVE; POLYCYCLIC AROMATIC HYDROCARBON; PYRROLIZIDINE ALKALOID; QUINONE DERIVATIVE; RADICAL; SAFROLE;

CANCER RESEARCH; CARCINOGEN DNA INTERACTION; CHEMICAL CARCINOGENESIS; COOKING; DNA ADDUCT; FOOD COMPOSITION; FOOD INTAKE; HISTORY OF MEDICINE; HUMAN; LIFESTYLE; LUNG CANCER; LUNG CARCINOGENESIS; METABOLIC ACTIVATION; METABOLISM; NONHUMAN; OCCUPATIONAL EXPOSURE; OXIDATION REDUCTION REACTION; PRIORITY JOURNAL; REVIEW; STRUCTURE ACTIVITY RELATION; TOBACCO;

EID: 84870488012     PISSN: 09400745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-61737-995-6_1     Document Type: Review

References (147)

1. Baird WM, Dipple A, Grover PL, Sims P, Brookes P (1973). Cancer Res. 33:2386-2392.
2. Baird WM, Harvey RG, Brookes P (1975). Cancer Res. 35:54-57.
3. Beland FA, Harvey RG (1976). J. Chem. Soc. Chem. Commun. 84-85.
4. Beland FA, Kadlubar FF (1990). In Chemical Carcinogenesis and Mutagenesis I, Cooper CS, Grover PI (eds), Springer-Verlag, Berlin, pp. 267-325.
5. Bennett JW, Klich M (2003). Clin. Microbiol. Rev. 16:497-516.
6. Blobstein SH, Weinstein IB, Grunberger D, Weisgras J, Harvey RG (1975). Biochemistry 14:3451-3458.
7. Boffetta P, Jourenkova N, Gustavasson P (1997). Cancer Causes Control 8:444-472.
8. Bolton JL, Acay NM, Vukomanovic V (1994). Chem. Res. Toxicol. 7:443-450.
9. Borchert P, Miller JA, Miller EC, Shires TK (1973). Cancer Res. 33:590-600.
10. Borgen A, Darvey H, Castagnoli N, Crocker TT, Rasmussen RE, Wang IY (1973). J. Med. Chem. 16:502-506.
11. Boyland E (1950). Biochem. Soc. Symp. 5:40-54.
12. Brooks P, Lawley PD (1964). Nature 202:781-784.
13. Busby WF, Wogan GN (1984). In Chemical Carcinogens, Searle CE (ed), Vol. 2, American Chemical Society, Washington, DC, pp. 945-1169 (ACS Monograph 182).
14. Cavalieri EL, Rogan EG, Roth RW, Saugier RK, Hakam K (1983). Chem. Biol. Interact. 47:87-109.
15. Cavalieri E, Rogan E (1985). In Polycyclic Hydrocarbons and Carcinogenesis, Harvey RG (ed), ACS. Symp. Series 283, American Chemical Society, Washington, DC, pp. 289-305.
16. Cavalieri EL, Higginbotham S, RamaKrishna NSV, Devanesan PD, Todorovic R, Rogan EG, Salmasi S (1991). Carcinogenesis 12:1939-1944.
17. Cavalieri E, Rogan E (1995). Xenobiotica 25:677-688.
18. Cavalieri EL, Rogan EG, Li K-M, Todorovic R, Ariese F, Jankowiak R, Grubor N, Small GJ (2005). Chem. Res. Toxicol. 18:976-983.
19. Chen L, Devanesan PD, Higginbotham S, Ariese F, Jankowiak R, Small GJ, Rogan EG, Cavalieri EL (1996). Chem. Res. Toxicol. 9:897-903.
20. Cheng KC, Cahill DS, Kasai H, Nishimura S, Loeb LA (1992). J. Biol. Chem. 267:166-172.
21. Chung Y-T, Chen C-L, Wu C-C, Chan S-A, Chi C-W, Liu T-Y (2008). Toxicol. Lett. 183:21-27.
22. Conney A (1982). Cancer Res. 42:4875-4917.
23. Cook JW, Hewett CL, Hieger I (1933). J. Chem. Soc. 395-405.
24. Cramer JW, Miller JA, Miller EC (1960). J. Biol. Chem. 235:885-888.
25. Dai Q, Ran C, Harvey RG (2005). Org. Lett. 5:999-1002.
26. Dai Q, Xu D, Lim K, Harvey RG (2007). J. Org. Chem. 72:4856-4863.
27. Dansette P, Jerina DM (1974). J. Am. Chem. Soc. 96:1224-1225.
28. Devanesan PD, RamaKrishna NVS, Todorovic R, Rogan EG, Cavalieri EL, Jeong H, Jankowiak R, Small GJ (1992). Chem. Res. Toxicol. 5:302-309.
29. Diechmann WBJ, Radomski J, Glass E, Coplan M, Woods F (1965). Ind. Med. Surg. 34:640-649.
30. Doll R, Peto R (1981). J. Natl. Cancer Inst. 66:1191-1308.
31. Eaton DL, Gallagher, EP (1994). Ann. Rev. Pharmacol. Toxicol. 34:135-172.
32. Ender F, Favre G, Helgebostad A, Koppang N, Madsen R, Ceh I (1964). Naturwissenschaften 51:637-638.
33. Freundenthal RI, Stephens E, Anderson DP (1999). Int. J. Toxicol. 18:353-359.
34. Fu PP, Harvey, RG, Beland FA (1978). Tetrahedron 34:857-866.
35. Fu PP, Chou MW, Xia Q, Yang Y-C, Yan J, Doerge DR, Chan PC (2001). Environ. Carcinog. Ecotoxicol. Rev. C19:363-385.
36. Fujita J, Sirvastava SK, Kraus MH, Rhim JS, Tronik SR, Aaronson SA (1985). Proc. Natl. Acad. Sci. USA 82:3849-3853.
37. Goh SH, Harvey RG (1978). J. Am. Chem. Soc. 95:242-243.
38. Goshman LM, Heidelberger C (1967). Cancer Res. 27:1678-1688.
39. Gozukara EH, Belvedere, G, Robinson RC, Deutsch J, Guengerich FP, Gelboin HV (1981). Mol. Pharmacol. 19:153-161.
40. Grasso P (1984). In Chemical Carcinogens, Searle CE (ed), Vol. 2, American Chemical Society, Washington, DC, pp. 1205-1239 (ACS Monograph 182).
41. Grimmer G (1983). Environmental carcinogens: polycyclic aromatic hydrocarbons, chemistry, occurrence, biochemistry, carcinogenicity, CRC Press, Boca Raton, FL.
42. Grover PL, Sims P (1968). Biochem. J. 110:159-160.
43. Guengerich FP, Johnson WW, Shimada T, Ueng Y-F, Yamazaki H, Langouët S (1998). Mutat. Res. 402:121-128.
44. Harris C (1989). Carcinogenesis 10:1563-1566.
45. Harvey R (1991). In Polycyclic Aromatic Hydrocarbons: Chemistry and Carcinogenicity. Cambridge Monographs on Cancer Research, Coombs MM (ed), Cambridge University Press, Cambridge, UK.
46. Harvey RG, Dai Q, Ran C, Lim KP, Blair, IA, Penning TM (2005). Polycycl. Aromat. Compd. 25:371-391.
47. Harvey RG, Geacintov NE (1988). Acc. Chem. Res. 21:66-73.
48. Harvey RG, Goh SH, Cortez C (1975). J. Am. Chem. Soc. 97:3468-3469.
49. Hatanaka N, Yamazaki H, Oda Y, Guengerich FP, Nakajima M, Yokoi T (2001). Mutat. Res. 497:223-233.
50. Hecht SS (1998). Chem. Res. Toxicol. 11:559-603.
51. Hecht SS (2008). Chem. Res. Toxicol. 21:160-171.
52. Hecht SS, Amin S, Melikian AA, LaVoie EJ, Hoffmann D (1985). In Polycyclic Hydrocarbons and Carcinogenesis, Harvey RG (ed), ACS Symp. Series No. 283, American Chemical Society, Washington, DC, 41-163.
53. Higginson J, Muir CS, Munoz, N (1992). Human Cancer: Epidemiology and Environmental Causes. Cambridge Monographs on Cancer Research, Coombs MM (ed), Cambridge University Press, Cambridge, UK.
54. Hill J (1761). Cautions against the immoderate use of snuff founded on the known qualities of the tobacco plant and the effects it must produce when in this Way Taken into the Body; and enforced by instances of persons Who have Perished Miserably of Disease, Occassioned, or Rendered Incurable by its Use. Baldwin and Jackson, London UK.
55. Huberman E, Sachs L, Yang SK, Gelboin HV (1976). Proc. Natl. Acad. Sci. USA. 73:607-611.
56. Huggins CB, Pataki J, Harvey RG (1967). Proc. Natl. Acad. Sci. USA. 58:2253-2260.
57. IARC (1976). IARC Monographs on the evaluation of the carcinogenic risk of chemicals to humans: Some naturally occurring substances, Vol. 10, IARC, Lyon, France.
58. IARC (1983). IARC Monographs on the evaluation of the carcinogenic risk of chemicals to humans: Polynuclear aromatic compounds, Vol. 32, IARC, Lyon, France.
59. IARC (1987). Overall evaluations of carcinogenicity. IARC Monographs on the evaluation of the carcinogenic risk of chemicals to humans, Supplement 7, IARC, Lyon, France.
60. IARC (1993). IARC Monographs on the evaluation of the carcinogenic risk of chemicals to humans: Some naturally occurring substances: food items and constituents, heterocyclic aromatic amines and mycotoxins, Vol. 56, IARC, Lyon, France.
61. IARC (2002). IARC Monographs on the evaluation of the carcinogenic risk of chemicals to humans: Traditional herbal medicines, some mycotoxins, naphthalene and styrene, Vol. 82, IARC, Lyon, France.
62. IARC (2004). IARC Monographs on the evaluation of carcinogenic risks to humans: Tobacco smoke and involuntary smoking, Vol. 83, IARC, Lyon, France.
63. IARC (2007). IARC Monographs on the evaluation of carcinogenic risks to humans: Smokeless tobacco smoke, Vol. 89, IARC, Lyon, France.
64. Iyer R, Coles B, Raney KD, Thier R, Guengerich FP, Harris TM (1994). J. Am. Chem. Soc. 116:1603-1609.
65. Jager J (1978). J. Chromatogr. 152:573-578.
66. Jeffrey AM, Jennette K, Blobstein SH, Weinstein IB, Beland FA, Harvey RG, Kasai H, Miura I, Nakanishi K (1976). J. Am. Chem. Soc. 98:5714-5716.
67. Jeffrey AM, Weinstein IB, Jennette K, Grzeskowiak K, Nakanishi K, Harvey RG, Autrup H, Harris C (1977). Nature (London) 269:348-350.
68. Jeffrey AM, Williams GM (2005). Toxicol. Appl. Pharmacol. 207:S628-S635.
69. Jennette KW, Jeffrey AM, Blobstein SH, Beland FA, Harvey RG, Weinstein IB (1977) Biochemistry 16:932-938.
70. Jerina DM, Daly JW (1977). In Drug Metabolism-From Microbe to Man, Parke DV, Smith RI (eds), Taylor & Francis, London.
71. Keefer LE, Roller PP (1973). Science 181:1245-1247.
72. King CM, Glowinski IB (1983). Environ. Health Perspect. 49:43-50.
73. King HWS, Osborne MR, Beland FA, Harvey RG, Brookes P (1976). Proc. Natl. Acad. Sci. USA 73:2679-2681.
74. Kinosita R (1936). Gann 30:423-426.
75. Kmet J (1970). J. Chronic Dis. 23:305-315.
76. Kolonel LN, Altshuler D, Henderson BE (2004). Nat. Rev. Cancer 4:519-527.
77. Lai C-C, Miller JA, Miller EC, Liem A (1985). Carcinogenesis 6:1037-1045.
78. Lawley PD (1990). In Handbook of Experimental Pharmacology, Cooper CS, Grover PI (eds), Vol. 94/1, Springer-Verlag, Berlin, pp. 409-469.
79. Lehr R, Kumar S, Levin W, Wood AW, Chang RL, Conney A, Yagi H, Sayer JM, Jerina DM (1985). In Polycyclic Hydrocarbons and Carcinogenesis, Harvey RG (ed), American Chemical Society, Washington, DC, pp. 63-84 (ACS Monograph 283).
80. Leung AY (1980). Encyclopedia of common natural ingredients used in foods, drugs, and natural cosmetics, Wiley, New York.
81. Levin W, Wood AW, Chang RL, Slaga, TJ, Yagi H, Jerina DM, Conney AH (1977). Cancer Res. 37:2721-2725.
82. Lijinsky W (1999). Mutat. Res. 443:129-138.
83. Lindahl T, Nyberg B (1972). Biochemistry 11:3610-3616.
84. Loeb LA, Harris C (2008). Cancer Res. 68:6863-6872.
85. Löfroth G, Hefner E, Alfeim I, Møeller M (1980). Science 209:1037-1039.
86. Luch A (2005). Nat. Rev. Cancer 5:113-125.
87. Magee PN, Barnes JM (1956). Br. J. Cancer 10:114-122.
88. Magee PN, Farber E (1962). Biochem. J. 83:114-124.
89. Magee PN, Hultin T (1962). Biochem. J. 83:106-114.
90. Mangino M, Scanlan RA, O'Brien TJ (1981). In N-Nitroso Compounds, Scanlan RA, Tannenbaum SR (eds), ACS Symp. Series No. 174, American Chemical Society, Washington, DC, pp. 229-245.
91. Mattocks AR (1968). Nature (London) 217:723-728.
92. Mattocks AR (1986). Chemistry and toxicology of pyrrolizidine alkaloids, Academic Press, London.
93. McCoull KD, Rindgen D, Blair IA, Penning TM (1999). Chem. Res. Toxicol. 12:237-246.
94. Meehan T, Straub K, Calvin M (1977). Nature (London) 269:725-727.
95. Melendez-Colon V, Luch A, Seidel A, Baird W (1999). Carcinogenesis 20:1885-91.
96. Miller EC, Miller JA (1966). Pharmacol. Rev., Part II 18:805-838.
97. Miller EC, Miller JA (1981). Cancer 47:2327-2345.
98. Miller JA, Miller EC, Hartmann HA (1961). Cancer Res. 21:815-824.
99. Nakanishi K, Kasai H, Cho H, Harvey RG, Jeffrey AM, Jennette KW, Weinstein IB (1977). J. Am. Chem. Soc. 99:258-260.
100. National Research Council (1996). Carcinogens and anticarcinogens in the human diet, National Academy Press, Washington, DC.
101. National Toxicology Program (1996). Toxicology Publ. No. 34, U.S. DHHS, Washington, DC.
102. Newbold RF, Brookes P (1976). Nature 261:52-54.
103. Oesch F (1980). In Microsomal Epoxide Hydrolase. Enzymatic Basis of Detoxification. II, Jacoby WB (ed), Academic Press, New York, pp. 277-290.
104. Oesch F, Timms CW, Walker CH, Guenther TM, Sparrow A, Watabe T, Wolf CR (1984) Carcinogenesis 5:7-9.
105. Park J-H, Gopishetty S, Szewczuk LM, Troxel AB, Harvey RG, Penning TM (2005). Chem. Res. Toxicol. 18:1026-1037.
106. Park J-H, Troxel AB, Harvey RG, Penning TM (2006). Chem. Res. Toxicol. 19:719-728.
107. Park J-H, Mangal D, Tacka KA, Quinn AM, Harvey RG, Blair IA, Penning TM (2008). Proc. Natl. Acad. Sci. USA 105:6845-6851.
108. Penning TM, Burczyski ME, Hung C-F, McCoull KD, Palackal NT, Tsuruda, LS (1999). Chem. Res. Toxicol. 12:1-18.
109. Peto J (2001). Nature 411:390-395.
110. Pitts JN Jr, van Cauwenberghe KA, Grosjean D, Schmidt JP, Fitz DR, Belser WL Jr, Knudson GB, Hynds PM (1978). Science 202:515-519.
111. Pott P (1775). Chirugical observations relative to the cancer of the scrotum, Hawes, Clarke, and Collins, London. Reprinted in Natl. Cancer Inst. Monograph 10:7-13 (1963).
112. Poupko JM, Hearn WL, Radomski JL (1979). Toxicol. Appl. Pharm. 50:479-484.
113. Poirier MC, Hunt JM, True B, Laishes BA, Young JF, Beland FA (1988). Cancer Res. 5:1591-1596.
114. Preussmann R, Eisenbrand G (1984). In Chemical Carcinogens, Searle CE (ed), Vol. 2. American Chemical Society, Washington DC, pp. 829-868 (ACS Monograph 182).
115. Preussmann R, Stewart BW (1984). In, Chemical Carcinogens, Searle CE (ed), Vol. 2, American Chemical Society, Washington DC, pp. 643-828 (ACS Monograph 182).
116. Pullman A, Pullman B (1955). Adv. Cancer Res. 3:117-169.
117. Purohit V, Basu AK (2000). Chem. Res. Toxicol. 13:673-692.
118. Ran C, Dai Q, Ruan Q, Penning TM, Blair IA, Harvey RG (2008). J. Org. Chem. 73:992-1003.
119. Rehn L (1895). Arch. Klin. Chir. 50:588-600.
120. Rosenkranz HS, McCoy EC, Sanders DR, Butler M, Kiriazides DK, Mermelstein R (1980) Science 209:1039-1043.
121. Searle CE (1984). Chemical Carcinogens, Vol. 1&2, American Chemical Society, Washington, DC (ACS Monograph No. 182).
122. Searle CE, Teale OJ (1990). In Chemical Carcinogenesis and Mutagenesis I, Cooper CS, Grover PI (eds), Springer-Verlag, Berlin, pp. 103-151.
123. Shou M, Harvey RG, Penning TM (1993). Carcinogenesis 14:2707-2715.
124. Sims P, Grover PL, Swaisland A, Pal K, Hewer A (1974). Nature 252:326-328.
125. Singer B, Grunberger D (1989). Molecular biology of mutagens and carcinogens, Plenum Press, New York.
126. Slaga TJ, Gleason GL, Mills G, Ewald L, Fu PP, Lee HM, Harvey RG (1980). Cancer Res. 40:1981-1984.
127. Smithgall TE, Harvey RG, Penning TM (1986). J. Biol. Chem. 261:6184-6186.
128. Smithgall TE, Harvey RG, Penning TM (1988). J. Biol. Chem. 263:1814-1820.
129. Spiegelhalder B, Eisenbrand G, Preussmann R (1980). IARC Scientific publication No. 31, pp. 467-470.
130. Snyderwine EG, Turteltaub KW (2000). In Food Borne Carcinogens, Nagao M, Sugimura T (eds), Wiley, New York.
131. Stegelmeier BL, Edgar JA, Colegate SM, Gardener DR, Schoch TK, Coulombe RA Jr (1999) J. Nat. Toxins 8:95-116.
132. Sugimura T, Nagao M, Wakabayashi K (2000). Mutat. Res. 447:15-25.
133. Sugimura T, Wakabayashi K, Nakagama H, Nagao M (2004). Cancer Sci. 95:290-299.
134. Surgeon General (1964). Smoking and Health. Report of the Advisory Committee to the Surgeon General of the Public Health Service. Publication No. 1103, pp. 149-196, U.S. Govt. Printing Office, Washington, DC.
135. Tokiwa H, Ohnishi Y (1986). CRC Crit. Rev. Toxicol. 17:23-60.
136. Tsutsui H (1918). Gann 12:21.
137. Turesky RJ, Rossi SC, Welti D, Lay JO Jr, Kadlubar FF (1992). Chem. Res. Toxicol. 5:479-490.
138. Weinstein IB, Jeffrey AM, Jennette K, Blobstein S, Harvey RG, Harris C, Autrup H, Kasai H, Nakanishi K (1976). Science 193:592-595.
139. Wilson RH, DeEds F, Cox AJ (1941). Cancer Res. 1:595-608.
140. Wiseman RW, Fennell TR, Miller JA, Miller EC (1985). Cancer Res. 45:3096-3105.
141. Wood AW, Levin W, Lu AYH, Yagi H, Hernandez O, Jerina DM, Conney AH (1976). J. Biol. Chem. 251:4882-4890.
142. Xia Q, Chou MW, Kadlubar FF, Chan PC, Fu PP (2003). Chem. Res. Toxicol. 16:66-73.
143. Yagi H, Hernandez O, Jerina DM (1975). J. Am. Chem. Soc. 97:6881-6883.
144. Yamagawa K, Ichikawa K (1915). Mitt. Med. Fak. Kaiserl. Univ. Tokyo 15:295-344.
145. Yang SK, Roller PP, Fu PP, Harvey RG, Gelboin HV (1977). Biochem. Biophys. Res. Commun. 77:1176-1182.
146. Yang YC, Yan J, Doerge DR, Chan PC, Fu PP, Chou MW (2001). Chem. Res. Toxicol. 14:101-109.
147. Yoshida T (1933). Trans. Jpn. Pathol. Soc. 23:636-638.